Codexis (CDXS) Interest & Investment Income (2010 - 2026)
Codexis (CDXS) posted quarterly Interest & Investment Income of $665000.0 for Q1 2026, down 11.45% year-over-year from $751000.0 in Q1 2025, and up 1.37% quarter-over-quarter from $656000.0 in Q4 2025.
Codexis (CDXS) Interest & Investment Income (2010 - 2026) Analysis & Trends
Codexis' Interest & Investment Income history runs 17 years deep, the most recent figure standing at $665000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 11.45% year-over-year to $665000.0; the TTM figure through Mar 2026 stood at $2.5 million (down 27.71% YoY), while the FY2025 annual figure was $2.6 million, down 28.47% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $665000.0, up from $656000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.1 million in Q2 2023, with the low at $42000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $823000.0 (2022), against an average of $739588.2.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income tumbled 76.27% in 2022, then surged 2492.86% in 2023.
- Codexis' Interest & Investment Income stood at $823000.0 in 2022, then rose by 10.09% to $906000.0 in 2023, then advanced by 3.75% to $940000.0 in 2024, then plunged by 30.21% to $656000.0 in 2025, then gained by 1.37% to $665000.0 in 2026.
- Business Quant data shows CDXS's Interest & Investment Income at $665000.0 in Q1 2026, $656000.0 in Q4 2025, and $634000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | 535,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 535,000.00 |
| Mar 31, 2026 | 665,000.00 |
| Dec 31, 2025 | 656,000.00 |
| Sep 30, 2025 | 634,000.00 |
| Jun 30, 2025 | 584,000.00 |
| Mar 31, 2025 | 751,000.00 |
| Dec 31, 2024 | 940,000.00 |
| Sep 30, 2024 | 849,000.00 |
| Jun 30, 2024 | 972,000.00 |
| Mar 31, 2024 | 909,000.00 |
| Dec 31, 2023 | 906,000.00 |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 1.09 Mn |
| Dec 31, 2022 | 823,000.00 |
| Sep 30, 2022 | 436,000.00 |
| Jun 30, 2022 | 140,000.00 |
| Mar 31, 2022 | 42,000.00 |
| Dec 31, 2021 | 35,000.00 |
| Sep 30, 2021 | 41,000.00 |